Mannatech Inc
MTEX Nasdaq· Medicinal Chemicals & Botanical Products
Last close · Oct 27, 2026
$8.38
KIRA · Stoqly’s AI analyst, in plain words
- Mannatech Inc had $108M of revenue in fiscal 2025, down 8.3% on the year before. Over five years, revenue changed −6.5% a year on average.
- Its operating margin was −0.4%, down 1.6 pts: of every 100 in sales, about −0 is left after running the business.
- Mannatech Inc lost $15.2M in fiscal 2025.
- Free cash flow was −$4.3M in fiscal 2025, −4.0% of revenue.
- Mannatech Inc has $2.8M more cash than debt.
Market cap
$16.2M
P/E
—
Revenue
$108M
Net income
−$15.2M
Free cash flow
−$4.3M
Operating margin
−0.4%
Mannatech Inc in 30 seconds · fiscal 2025
Are sales growing?
−8.3%
No. Sales fell 8.3% last year.
Does it make a profit?
−14.1%
No. It lost money last year.
Does profit turn into cash?
−4.0%
No. It spent more cash than it brought in.
Is debt under control?
Net cash
Yes. It has more cash than debt.
How healthy are the accounts?
2 / 8
Weak. It passes 2 of 8 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Mannatech Inc does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Apr 15, 2026
- Legal name
- MANNATECH INC
- CIK
- 0001056358
Mannatech Inc · MTEX
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $160M | $137M | $132M | $118M | $108M |
| Revenue growth | 5.5% | −14.1% | −3.8% | −10.7% | −8.3% |
| Net interest income | $0.1M | $0.1M | $0.0M | −$0.3M | — |
| Gross margin | 78.6% | 75.9% | 78.0% | 77.6% | 74.9% |
| Operating margin | 5.7% | −0.3% | −0.7% | 1.2% | −0.4% |
| Net income | $9.8M | −$4.5M | −$2.2M | $2.5M | −$15.2M |
| Net margin | 6.2% | −3.3% | −1.7% | 2.1% | −14.1% |
| Diluted EPS | $4.71 | −$2.35 | −$1.20 | $1.32 | −$8.00 |
| Cash | |||||
| Cash from operations | $10.8M | −$2.6M | −$2.4M | $2.3M | −$3.0M |
| Capital expenditure | $0.7M | $1.1M | $0.7M | $0.3M | $1.4M |
| Free cash flow | $10.1M | −$3.7M | −$3.1M | $2.0M | −$4.3M |
| FCF margin | 6.3% | −2.7% | −2.4% | 1.7% | −4.0% |
| Dividends paid | $4.3M | $1.5M | $0.7M | $0.0M | — |
| Share buybacks | $5.1M | $2.0M | $0.2M | $0.0M | — |
| Share count change | −7.8% | −8.4% | −2.5% | 1.0% | 0.8% |
| Debt and strength | |||||
| Cash and short-term investments | $24.2M | $13.8M | $7.7M | $11.4M | $6.2M |
| Debt incl. finance leases | — | — | — | — | $3.4M |
| Shareholders' equity | $24.4M | $14.2M | $10.5M | $8.6M | −$5.2M |
| Net debt / EBITDA | — | — | — | — | −4.1x |
| Current ratio | 1.4x | 1.2x | 1.1x | 1.3x | 1.1x |
| Interest coverage | — | — | — | 5.1x | −1.0x |
| Returns and quality | |||||
| Return on equity | 39.1% | −23.3% | −18.2% | 26.1% | −897.3% |
| Return on tangible equity | 40.3% | −31.7% | −21.4% | 29.7% | — |
| Piotroski F-score | 8 | 3 | 4 | 5 | 2 |
| Altman Z'' | 3.6 | 1.2 | 0.4 | 1.7 | −1.4 |
Insiders bought, 12 months
$0.1M
2 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Mannatech Inc · MTEX
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $8.38 a share, the company is worth $16.2M.
Source: SEC EDGAR XBRL filings (CIK 0001056358). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.